MX354047B - Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori. - Google Patents

Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori.

Info

Publication number
MX354047B
MX354047B MX2013014340A MX2013014340A MX354047B MX 354047 B MX354047 B MX 354047B MX 2013014340 A MX2013014340 A MX 2013014340A MX 2013014340 A MX2013014340 A MX 2013014340A MX 354047 B MX354047 B MX 354047B
Authority
MX
Mexico
Prior art keywords
lactobacillus
stems
spray
dried
cells
Prior art date
Application number
MX2013014340A
Other languages
English (en)
Other versions
MX2013014340A (es
Inventor
Lang Christine
Arya Stefanie
Goelling Detlef
Holz Caterina
Original Assignee
Novozymes As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11169137A external-priority patent/EP2532354A1/de
Application filed by Novozymes As filed Critical Novozymes As
Publication of MX2013014340A publication Critical patent/MX2013014340A/es
Publication of MX354047B publication Critical patent/MX354047B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se refiere a cepas de lactobacilos y/o células de lactobacilos (bacterias ácido lácticas) secadas por aspersión y, a los usos de las mismas, en particular para composiciones farmacéuticas y alimenticias para el tratamiento y la profilaxis de las infecciones de Helicobacter pylori en humanos y animales.
MX2013014340A 2011-06-08 2012-06-08 Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori. MX354047B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11169137A EP2532354A1 (de) 2011-06-08 2011-06-08 Sprühgetrocknete Lactobacillus Stämme / Zellen und deren Verwendung gegen Helicobacter Pylori
EP11185851 2011-10-19
PCT/EP2012/060948 WO2012168468A1 (de) 2011-06-08 2012-06-08 Sprühgetrocknete lactobacillus stämme / zellen und deren verwendung gegen helicobacter pylori

Publications (2)

Publication Number Publication Date
MX2013014340A MX2013014340A (es) 2014-07-09
MX354047B true MX354047B (es) 2018-02-09

Family

ID=46489179

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013014340A MX354047B (es) 2011-06-08 2012-06-08 Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori.

Country Status (10)

Country Link
US (1) US20140147427A1 (es)
EP (1) EP2717890B1 (es)
JP (1) JP6062931B2 (es)
CN (1) CN103648511B (es)
BR (1) BR112013031325A2 (es)
EA (1) EA028340B1 (es)
ES (1) ES2600963T3 (es)
MX (1) MX354047B (es)
PL (1) PL2717890T3 (es)
WO (1) WO2012168468A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2776198T3 (es) * 2013-02-07 2020-07-29 Novozymes As Uso de leche desnatada como vehículo para una composición que comprende Lactobacillus
DE102014103832A1 (de) 2014-02-13 2015-08-13 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur Behandlung von Magenbeschwerden
US20160143317A1 (en) * 2014-11-24 2016-05-26 Nutrition Physiology Company, Llc Lactic acid bacterium as pet dietary supplement
JP2016150904A (ja) * 2015-02-16 2016-08-22 サントリーホールディングス株式会社 抗腫瘍剤
JP6339526B2 (ja) * 2015-05-22 2018-06-06 アサヒグループホールディングス株式会社 筋肉の分解抑制剤
CN105132329B (zh) * 2015-09-14 2019-04-16 西南民族大学 一种可预防胃溃疡的发酵乳杆菌Lactobacillus fermentum strain Lee及其保健用途
GB2544481B (en) * 2015-11-16 2019-12-11 Century International Enterprises Ltd A wearable article and a method for producing a wearable article
SG11201810492QA (en) * 2016-06-20 2019-01-30 Meiji Co Ltd Upper gastrointestinal flora-improving agent
KR101873899B1 (ko) * 2016-08-09 2018-07-03 씨제이제일제당(주) 락토바실러스 살리바리우스 cjls1511, 상기 균 또는 이의 사균체를 포함하는 동물 사료 첨가제 조성물, 및 상기 사균체의 제조 방법
SG11201908857QA (en) * 2017-04-11 2019-10-30 Servatus Ltd Methods for the treatment of inflammation and inflammatory conditions
CN107361232A (zh) * 2017-06-21 2017-11-21 安徽和盛伟业饲料有限公司 一种防治仔鸡冬季腹泻的饲料
CN108403725B (zh) * 2018-05-22 2021-02-09 浙江海正药业股份有限公司 用于治疗消化道溃疡的组合物及其应用
US11617772B2 (en) * 2018-09-11 2023-04-04 Direct Digital Llc Nutritional supplements and therapeutic compositions comprising probiotics
US11963986B2 (en) 2018-10-24 2024-04-23 Novozymes A/S Probiotic supplement for metabolic health
WO2021099655A1 (es) * 2019-11-19 2021-05-27 Inbiolev, S.L. Procedimiento para el tratamiento de mostos y vinos y producto para la puesta en práctica del mismo
CN111357841A (zh) * 2020-03-26 2020-07-03 湖南营养树生物科技有限公司 一种抗幽门螺旋杆菌的益生菌白茶的制备方法
CN111548970B (zh) * 2020-05-29 2021-03-26 江南大学 一株能够预防和/或治疗幽门螺杆菌感染的卷曲乳杆菌
CN111471626A (zh) * 2020-05-29 2020-07-31 江南大学 一株能够抑制幽门螺杆菌的瑞士乳杆菌及其应用
CN111632084B (zh) * 2020-06-22 2024-04-26 上海利康精准医疗技术有限公司 一种抑制幽门螺旋杆菌的复合益生菌组合物及其应用
CN112314951A (zh) * 2020-12-04 2021-02-05 王立强 一种可抗幽门螺杆菌的组合物及其制备方法
CN114561313B (zh) * 2021-08-26 2022-09-13 佛山市孛特碧欧微生物科技有限公司 格氏乳杆菌及其应用
CN116004456B (zh) * 2022-12-27 2023-10-27 广西爱生生命科技有限公司 一株抑制幽门螺旋杆菌感染的罗伊氏乳杆菌a21325及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897307A (en) * 1974-10-23 1975-07-29 Hansens Lab Inc Stabilized dry cultures of lactic acid-producing bacteria
DE3135329A1 (de) 1981-09-05 1983-03-24 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von trockenpulvern oxidationsempfindlicher substanzen
EP0285682B2 (en) 1987-04-06 1997-08-06 F. Hoffmann-La Roche Ag Process for the manufacture of vitamin preparations
US5716615A (en) 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
JP3046303B1 (ja) * 1999-06-24 2000-05-29 明治乳業株式会社 Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ除菌性飲食品
JP4509250B2 (ja) * 1999-06-24 2010-07-21 明治乳業株式会社 Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ除菌性医薬品
FR2801316B1 (fr) * 1999-11-18 2005-03-25 Rhodia Food Procede de sechage des bacteries
JP3363438B2 (ja) * 2000-05-02 2003-01-08 ビオフェルミン製薬株式会社 噴霧乾燥による菌体乾燥物
EE04580B1 (et) * 2001-06-29 2006-02-15 Tartu �likool Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum
US7101565B2 (en) * 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
ATE492166T1 (de) * 2002-04-05 2011-01-15 Nestle Sa Zusammensetzungen und verfahren zur verbesserung von lipidassimilation in haustieren
AU2003224355A1 (en) 2003-04-02 2004-10-25 Axcel Photonics, Inc. Lactobacillus fermentum strain and uses thereof
AU2006296837B2 (en) * 2005-09-28 2012-12-13 Nordic Rebalance A/S Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors
DE102005062731A1 (de) * 2005-12-22 2007-06-28 Organobalance Gmbh Neue Lactobacillus Stämme und deren Verwendung
US9084434B2 (en) * 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
EP2087094B1 (en) * 2006-11-17 2014-02-26 SCA Hygiene Products AB Lactobacillus fermentum ess-1, dsm17851 and its use for the treatment and/or prevention of candidiasis and urinary tract infections
EP1992351B1 (en) * 2007-05-18 2016-05-11 Nestec S.A. Lactobacillus johnsonii for prevention of postsurgical infection
EP2206505B1 (en) * 2008-06-26 2013-07-31 Shinwa Pharmaceutical Co., Ltd. Nano-level lactic acid bacterium

Also Published As

Publication number Publication date
ES2600963T3 (es) 2017-02-13
EA028340B1 (ru) 2017-11-30
EA201391823A1 (ru) 2014-04-30
WO2012168468A1 (de) 2012-12-13
MX2013014340A (es) 2014-07-09
EP2717890A1 (de) 2014-04-16
JP6062931B2 (ja) 2017-01-18
JP2014518897A (ja) 2014-08-07
CN103648511B (zh) 2018-12-07
US20140147427A1 (en) 2014-05-29
EP2717890B1 (de) 2016-08-10
CN103648511A (zh) 2014-03-19
PL2717890T3 (pl) 2017-12-29
BR112013031325A2 (pt) 2017-06-06

Similar Documents

Publication Publication Date Title
MX354047B (es) Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori.
MX347262B (es) Preparaciones de alimento para mascotas que contienen microorganismos probióticos.
MX2019009132A (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
MX350325B (es) Bacteria para usarse como un probiotico para aplicaciones nutricionales y medicas.
WO2012112777A3 (en) Biosynthesis of human milk oligosaccharides in engineered bacteria
MX2017014787A (es) Poblaciones bacterianas para promover la salud.
MY173382A (en) Infant feeding formulas comprising probiotic micro-organisms
WO2014018596A3 (en) Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides
MX2013004372A (es) Productos de confiteria que contienen microorganismos probioticos.
NZ709392A (en) Synergistic bacterial compositions and methods of production and use thereof
IN2012DN01638A (es)
BR112015027536A8 (pt) composição compreendendo bactérias ácidas lácticas para utilização no tratamento preventivo e/ou curativo de cistite recorrente.
NZ706636A (en) Probiotic and prebiotic compositions
MX2015012379A (es) Novedosas cepas de lactobacillus y los usos de las mismas.
PH12017500708A1 (en) Probiotic and prebiotic compositions
PH12014501369A1 (en) Oral care compositions
HK1219501A1 (zh) 新型乳酸菌、以新型乳酸菌作為有效成分的天然免疫活化劑以及含有新型乳酸菌的飲食品
WO2012040804A3 (en) Synergistic combinations of triazoles, strobilurins and benzimidazoles, uses, formulations, production processes and applications using the same
NZ741342A (en) Daptomycin formulations and uses thereof
MX2019015306A (es) Probioticos y metodos de uso.
MX2012007970A (es) Proceso para la preparacion de una biomasa que comprende plantaricina y usos de la misma en el campo medico.
PH12019501439A1 (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
MX2017007969A (es) Bacterias de acido lactico y su uso para el tratamiento de mastitis.
IN2012DN01214A (es)
WO2014167582A3 (en) Vaccine composition for prophylaxis in ruminants

Legal Events

Date Code Title Description
GB Transfer or assignment

Owner name: NOVOZYMES A/S

FG Grant or registration